Pharmaceutical

Bristol-Myers Squibb (NYSE:BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended expanded approval of the current indications for Opdivo (nivolumab) to include the adjuvant treatment of adult patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection. As quoted in the …

Bristol-Myers Squibb (NYSE:BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended expanded approval of the current indications for Opdivo (nivolumab) to include the adjuvant treatment of adult patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection.

As quoted in the press release:

“This positive opinion supports the potential of Opdivo in the adjuvant setting to prevent relapse and progression to an advanced stage,” said Arvin Yang, M.D., Ph.D., development lead, melanoma and genitourinary cancers, Bristol-Myers Squibb. “We look forward to the upcoming EC decision and the potential opportunity to bring Immuno-Oncology treatment options to more patients across the European Union.”

The CHMP recommendation is based on data from the phase 3 CheckMate -238 trial, an ongoing, randomized double-blind study of Opdivo 3 mg/kg versus Yervoy (ipilimumab) 10 mg/kg in patients who have undergone complete resection of stage IIIB/C or stage IV melanoma according to the AJCC Cancer Staging Manual 7th edition. The U.S. Food and Drug Administration (FDA) expanded the approval of Opdivo to include the adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection in December 2017.

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20361.69+75.49
TSXV697.98-2.68
DOW31980.39+51.77
S&P 5003958.94+17.46
NASD11355.39+90.94
ASX7128.80-20.10

COMMODITIES

Commodities
Gold1846.48-20.80
Silver21.89-0.24
Copper4.25-0.05
Palladium2008.00+11.00
Platinum949.50-6.50
Oil109.64-0.13
Heating Oil3.69+0.03
Natural Gas9.20+0.40

DOWNLOAD FREE REPORTS

×